CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications.
St Sauver JL, Olson JE, Roger VL, Nicholson WT, Black JL 3rd, Takahashi PY, Caraballo PJ, Bell EJ, Jacobson DJ, Larson NB, Bielinski SJ.
St Sauver JL, et al.
Pharmgenomics Pers Med. 2017 Jul 24;10:217-227. doi: 10.2147/PGPM.S136341. eCollection 2017.
Pharmgenomics Pers Med. 2017.
PMID: 28769582
Free PMC article.